FIELD: medicine, pharmaceutics.
SUBSTANCE: group of inventions refers to pharmacology and medicine and concerns a composition representing a liposome in a medium having an internal cavity separated from the medium by means of a membrane comprising one or more lipids with the internal cavity of the liposome comprising a cationic antineoplastic therapeutic agent, as well as polyol or sugar polyanion-exchanged by means of at least two high-anionic functional groups; sugar represents monosaccharide or disaccharide, wherein the cationic agent and polyanion-exchanged polyol or polyanion-exchanged sugar are presented in the form of an acid or salt, as well as contained inside the liposome, wherein the composition represents a dosage form for parenteral administration, as well as concerns a method for encapsulating the cationic antineoplastic therapeutic agent in the liposome.
EFFECT: group of inventions provides the high-load effectiveness delivery of therapeutic agents to a site, wherein a pathological process is localised.
66 cl, 74 ex, 40 tbl, 47 dwg
Title | Year | Author | Number |
---|---|---|---|
LIPOSOMAL COMPOSITIONS USED FOR DRUG DELIVERY | 2015 |
|
RU2757110C2 |
LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
LIPOSOME HAVING INNER AQUEOUS PHASE AND CONTAINING SULPHOBUTYL ESTER CYCLODEXTRIN SALT | 2010 |
|
RU2575793C2 |
STABILIZED PHARMACEUTICAL COMPOSITIONS OF CAMPTOTHECIN | 2016 |
|
RU2732567C2 |
LIPOSOMAL COMPOSITION AND PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2734900C1 |
LIPOSOMES USED FOR DELIVERY OF MEDICATIONS | 2005 |
|
RU2424792C2 |
IRINOTECAN LIPOSOMES OR ITS SALTS, METHOD FOR PREPARING THEM | 2009 |
|
RU2526114C2 |
NEW LIPOSOME COMPOSITIONS | 2006 |
|
RU2454229C2 |
IMMUNOLIPOSOMAL FORM OF PHOTOSENSITISER | 2009 |
|
RU2410090C1 |
CREATING CONTROLLED RELEASE PROFILE OF DRUG SUBSTANCE USING LIPOSOMAL COMPOSITION IN AQUEOUS AND ANHYDROUS SOLUTIONS | 2014 |
|
RU2712157C2 |
Authors
Dates
2016-02-10—Published
2005-05-02—Filed